Ramsay Générale de Santé
France · FR0000044471 · reports in EUR · Europe
The answers
From the annual report for the year to Jun 30, 2025. Each line says what it is based on.
- Is it growing?Fair
- Revenue +4.7% in the year to Jun 30, 2025, on the year before.
- Is it a good business?To watch
- It earned −4.7% on its shareholders' equity in the year to Jun 30, 2025.
- Is it safe?To watch
- Equity is 17% of its assets, and operations brought in cash in the year.
- Is the price fair?n/a
- Not answered: no exchange publishes this company's price for free reuse, so there is no P/E here.
The year
Year to Jun 30, 2025, consolidated, in EUR.
€5.2B
revenue
3.3%
operating margin
−€54M
net profit
Year by year
As filed; an earlier year can differ from its own report when the company restated it.
| Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 | |
|---|---|---|---|---|
| Revenue | €4.3B | €4.7B | €5.0B | €5.2B |
| Operating profit | €291M | €240M | €161M | €173M |
| Net profit to shareholders | €118M | €49M | −€54M | −€54M |
| Earnings per share | €1.07 | €0.45 | −€0.49 | −€0.49 |
| Dividend per share | €0.00 | €0.00 | n/a | €0.00 |
| Cash from operations | €263M | €599M | €587M | €694M |
| Cash | €133M | €352M | €359M | €367M |
| Total assets | €6.8B | €7.0B | €6.9B | €6.8B |
| Equity | €1.2B | €1.3B | €1.2B | €1.2B |
What they do
In the company's own words, from the annual report.
exerce la totalité de ses activités dans le secteur Soins et Services Hospitaliers
Source: the company’s annual financial report in ESEF, via filings.xbrl.org (XBRL International). Listed shares from ESMA’s FIRDS register; ESMA does not endorse this site. Ryufin computed the answers and ratios from the filed figures.